STOCK TITAN

[S-8] Know Labs, Inc. Employee Benefit Plan Registration

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
S-8

Registration of additional shares: Know Labs, Inc. filed a Form S-8 on August 5, 2025 to register 48,950,000 additional shares of common stock under the Know Labs, Inc. 2021 Equity Incentive Plan following stockholder approval on July 31, 2025.

Administrative details: The filing incorporates prior Form S-8 registrations (Dec 10, 2021 and Apr 25, 2025), reflects the 1-for-40 reverse split effective Feb 19, 2025, and includes related exhibits and legal consents.

Registrazione di azioni aggiuntive: Know Labs, Inc. ha presentato un Modulo S-8 il 5 agosto 2025 per registrare 48,950,000 azioni ordinarie aggiuntive nell'ambito del Know Labs, Inc. 2021 Equity Incentive Plan, a seguito dell'approvazione degli azionisti del 31 luglio 2025.

Dettagli amministrativi: Il deposito incorpora le precedenti registrazioni S-8 (10 dic 2021 e 25 apr 2025), riflette il frazionamento inverso 1-per-40 effettivo dal 19 feb 2025 e include gli allegati e i consensi legali correlati.

Registro de acciones adicionales: Know Labs, Inc. presentó un Formulario S-8 el 5 de agosto de 2025 para registrar 48,950,000 acciones ordinarias adicionales bajo el Know Labs, Inc. 2021 Equity Incentive Plan, tras la aprobación de los accionistas el 31 de julio de 2025.

Detalles administrativos: La presentación incorpora registros S-8 previos (10 dic 2021 y 25 abr 2025), refleja la consolidación inversa 1-por-40 con efecto el 19 feb 2025 e incluye los anexos y consentimientos legales relacionados.

추가 주식 등록: Know Labs, Inc.는 2025년 8월 5일 Form S-8을 제출하여 2025년 7월 31일 주주 승인에 따라 Know Labs, Inc. 2021 Equity Incentive Plan에 따라 48,950,000주의 보통주를 추가로 등록했습니다.

행정 사항: 이번 제출은 이전의 Form S-8 등록(2021년 12월 10일 및 2025년 4월 25일)을 포함하며, 2025년 2월 19일부로 효력 발생한 1대40 역병합을 반영하고 관련 전시 문서 및 법적 동의서를 포함합니다.

Enregistrement d'actions supplémentaires : Know Labs, Inc. a déposé un formulaire S-8 le 5 août 2025 pour enregistrer 48,950,000 actions ordinaires supplémentaires dans le cadre du Know Labs, Inc. 2021 Equity Incentive Plan, suite à l'approbation des actionnaires le 31 juillet 2025.

Détails administratifs : le dépôt incorpore les enregistrements S-8 antérieurs (10 déc. 2021 et 25 avr. 2025), reflète le regroupement d'actions inverse 1 pour 40 effectif le 19 fév. 2025 et inclut les annexes et consentements juridiques associés.

Registrierung zusätzlicher Aktien: Know Labs, Inc. reichte am 5. August 2025 ein Formular S-8 ein, um 48,950,000 zusätzliche Stammaktien im Rahmen des Know Labs, Inc. 2021 Equity Incentive Plan zu registrieren, nach der Zustimmung der Aktionäre am 31. Juli 2025.

Verwaltungsdetails: Die Einreichung umfasst frühere Form S-8-Registrierungen (10. Dez. 2021 und 25. Apr. 2025), berücksichtigt den 1-zu-40 Reverse-Split mit Wirkung zum 19. Feb. 2025 und enthält die zugehörigen Anlagen und rechtlichen Zustimmungen.

Positive
  • 48,950,000 additional shares registered under the Know Labs, Inc. 2021 Equity Incentive Plan following stockholder approval on July 31, 2025
  • Prior Form S-8s incorporated by reference (Dec 10, 2021 and Apr 25, 2025), with adjustment for the 1-for-40 reverse split effective Feb 19, 2025
  • Exhibits and legal consents included, such as the Certificate of Amendment, Plan amendment, legal opinion, and auditor consent
Negative
  • None.

Insights

TL;DR: Administrative registration adds 48,950,000 shares to the equity incentive pool; no earnings or transaction metrics disclosed.

The Form S-8 registers 48,950,000 additional shares under the 2021 Equity Incentive Plan after stockholder approval on July 31, 2025. The filing incorporates prior S-8s and notes adjustment for the 1-for-40 reverse split effective February 19, 2025. No financial results, guidance, material contracts, or dilution schedules are provided in this statement.

Impact Assessment: Not impactful to immediate valuation absent issuance details; useful disclosure for potential future equity grants.

TL;DR: Governance update documents shareholder-approved amendment and supporting exhibits; standard power of attorney and legal opinions attached.

The registration documents the Plan amendment approved at the special meeting on July 31, 2025 and files the Certificate of Amendment and amendment to the Equity Incentive Plan as exhibits. It includes legal opinion, auditor consent, and power of attorney signatures dated August 5, 2025, indicating procedural completion of the registration process.

Impact Assessment: Not impactful on corporate control; procedural governance compliance is documented.

Registrazione di azioni aggiuntive: Know Labs, Inc. ha presentato un Modulo S-8 il 5 agosto 2025 per registrare 48,950,000 azioni ordinarie aggiuntive nell'ambito del Know Labs, Inc. 2021 Equity Incentive Plan, a seguito dell'approvazione degli azionisti del 31 luglio 2025.

Dettagli amministrativi: Il deposito incorpora le precedenti registrazioni S-8 (10 dic 2021 e 25 apr 2025), riflette il frazionamento inverso 1-per-40 effettivo dal 19 feb 2025 e include gli allegati e i consensi legali correlati.

Registro de acciones adicionales: Know Labs, Inc. presentó un Formulario S-8 el 5 de agosto de 2025 para registrar 48,950,000 acciones ordinarias adicionales bajo el Know Labs, Inc. 2021 Equity Incentive Plan, tras la aprobación de los accionistas el 31 de julio de 2025.

Detalles administrativos: La presentación incorpora registros S-8 previos (10 dic 2021 y 25 abr 2025), refleja la consolidación inversa 1-por-40 con efecto el 19 feb 2025 e incluye los anexos y consentimientos legales relacionados.

추가 주식 등록: Know Labs, Inc.는 2025년 8월 5일 Form S-8을 제출하여 2025년 7월 31일 주주 승인에 따라 Know Labs, Inc. 2021 Equity Incentive Plan에 따라 48,950,000주의 보통주를 추가로 등록했습니다.

행정 사항: 이번 제출은 이전의 Form S-8 등록(2021년 12월 10일 및 2025년 4월 25일)을 포함하며, 2025년 2월 19일부로 효력 발생한 1대40 역병합을 반영하고 관련 전시 문서 및 법적 동의서를 포함합니다.

Enregistrement d'actions supplémentaires : Know Labs, Inc. a déposé un formulaire S-8 le 5 août 2025 pour enregistrer 48,950,000 actions ordinaires supplémentaires dans le cadre du Know Labs, Inc. 2021 Equity Incentive Plan, suite à l'approbation des actionnaires le 31 juillet 2025.

Détails administratifs : le dépôt incorpore les enregistrements S-8 antérieurs (10 déc. 2021 et 25 avr. 2025), reflète le regroupement d'actions inverse 1 pour 40 effectif le 19 fév. 2025 et inclut les annexes et consentements juridiques associés.

Registrierung zusätzlicher Aktien: Know Labs, Inc. reichte am 5. August 2025 ein Formular S-8 ein, um 48,950,000 zusätzliche Stammaktien im Rahmen des Know Labs, Inc. 2021 Equity Incentive Plan zu registrieren, nach der Zustimmung der Aktionäre am 31. Juli 2025.

Verwaltungsdetails: Die Einreichung umfasst frühere Form S-8-Registrierungen (10. Dez. 2021 und 25. Apr. 2025), berücksichtigt den 1-zu-40 Reverse-Split mit Wirkung zum 19. Feb. 2025 und enthält die zugehörigen Anlagen und rechtlichen Zustimmungen.

As filed with the Securities and Exchange Commission on August 5, 2025

 

Registration No. 333- ___

 

 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

KNOW LABS, INC.

(Exact name of Registrant as specified in its charter)

 

 

Nevada

 

90-0273142

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification Number)

 

619 Western Avenue, Suite 610

Seattle, Washington 98104

(Address, including zip code, of Registrant’s principal executive office)

 

Know Labs, Inc. 2021 Equity Incentive Plan

(Full title of the plan)

 

Ronald P. Erickson, Chairman of the Board

Know Labs, Inc.

619 Western Avenue, Suite 610

Seattle, WA 98104

206-903-1351

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

Copies to: 

Jessica M. Lockett, Esq.

Corporate Securities Legal, LLP

650 Town Center Dr., Suite 680

Costa Mesa, CA 92626

(949) 752-1100

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

 

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

 

 

 

 

 

EXPLANATORY NOTE

 

This Registration Statement is filed by Know Labs, Inc. (the “Registrant”) for the purpose of registering an additional 48,950,000 shares of the Registrant’s common stock, par value $0.001 per share (the “Common Stock”) issuable under the Know Labs, Inc. 2021 Equity Incentive Plan (the “Plan”) following the amendment to the Plan that was approved by the Registrant’s stockholders at its special meeting of stockholders on July 31, 2025 (“Special Meeting”).

 

In accordance with Instruction E to Form S-8, the contents of the following prior registration statement on Form S-8, previously filed with the Securities and Exchange Commission (the “Commission”) with respect to the Plan, are hereby incorporated by reference: (i) 866,253 shares of Common Stock on Form S-8 filed with the Commission on December 10, 2021 (File No. 333-261597), and (ii) 550,000 shares of Common Stock on Form S-8 filed with the Commission on April 25, 2025 (File No. 333-286762) (collectively (i) and (ii), the “Prior Registration Statements”). The shares registered under the December 10, 2021 Registration Statement have been adjusted as referenced herein to reflect the Registrants 1-for-40 reverse stock split of the issued and outstanding shares of Common Stock which became effective on February 19, 2025.

 

Pursuant to General Instruction E of Form S-8, the contents of Prior Registration Statements are incorporated into this Registration Statement by reference to the extent not modified or superseded hereby or by any subsequently filed document, which is incorporated by reference herein or therein.

 

 
2

 

 

PART I

INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

 

In accordance with the rules and regulations of the Commission, the information called for in Part I of Form S-8 is not being filed with or included in this Registration Statement or in a prospectus or prospectus supplement pursuant to Rule 424 of the Securities Act.

 

 
3

 

 

PART II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

 

Item 8. Exhibits.

 

A list of exhibits included as part of this Registration Statement is set forth in the Exhibit Index to this Registration Statement and is incorporated herein by reference.

 

Exhibit

Number

 

Exhibit Description

 

 

 

 

 

 

 

Filed herewith

 

Incorporated by Reference herein from Form or Schedule

 

Filing Date

 

3.1

 

Restatement of the Articles of Incorporation, dated August 11, 2023

 

 

 

Form 8-K

 

August 14, 2023

 

3.2

 

Certificate of Amendment to the Articles of Incorporation, dated July 31, 2025

 

 

 

Form 8-K

 

August 1, 2025

 

3.3

 

Second Amended and Restated Bylaws, dated October 15, 2021

 

 

 

Form 8-K

 

December 7, 2021

 

4.1

 

Amendment to Know Labs Inc. 2021 Equity Incentive Plan, dated July 31, 2025

 

 

 

Form 8-K

 

August 1, 2025

 

4.2

 

2021 Know Labs, Inc. Equity Incentive Plan, as amended

 

x

 

 

 

 

 

5.1

 

Opinion of Corporate Securities Legal, LLP, filed herewith

 

x

 

 

 

 

 

23.1

 

Consent of BPM LLP, independent registered public accounting firm

 

x

 

 

 

 

 

23.2

 

Consent of Corporate Securities Legal, LLP (included in Exhibit 5.1)

 

x

 

 

 

 

 

24.1

 

Power of Attorney (included on signature page hereto)

 

x

 

 

 

 

 

107

 

Filing Fee Table

 

x

 

 

 

 

 

 

 
4

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Seattle, Washington, on August 5, 2025.

 

 

Know Labs, Inc.

 

 

 

 

Date: August 5, 2025

By:

/s/ Ronald P. Erickson

 

 

 

Ronald P. Erickson

 

 

 

Chief Executive Officer, and

Chairman of the Board of Directors

(Principal Executive Officer)

 

 

POWER OF ATTORNEY

 

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Ronald P. Erickson and Peter J. Conley and each or any one of them, their true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for each of the undersigned in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Registration Statement on Form S-8, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the U.S. Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their substitutes or substitute, may lawfully do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities indicated:

 

Signature

 

Title

 

Date

 

 

 

 

 

/s/ Ronald P. Erickson

 

Chief Executive Officer, and Director

 

August 5, 2025

Ronald P. Erickson

 

(Principal Executive Officer)

 

 

 

 

 

 

 

/s/ Peter J. Conley

 

Chief Financial Officer

 

August 5, 2025

Peter J. Conley

 

(Principal Accounting Officer and

Principal Financial Officer)

 

 

 

 

 

 

 

/s/ William A. Owens

 

Director

 

August 5, 2025

William A. Owens

 

 

 

 

 

 

 

 

 

/s/ Jon Pepper

 

Director

 

August 5, 2025

Jon Pepper

 

 

 

 

 

 

 

 

 

/s/ Ichiro Takesako

 

Director

 

August 5, 2025

Ichiro Takesako

 

 

 

 

 

 

 

 

 

/s/ John Cronin

 

Director

 

August 5, 2025

John Cronin

 

 

 

 

 

 

 

 

 

/s/ Larry K, Ellingson

 

Director

 

August 5, 2025

Larry K. Ellingson

 

 

 

 

 

 
5

 

FAQ

What did Know Labs (KNW) register on Form S-8?

The company registered 48,950,000 additional shares of common stock issuable under the 2021 Equity Incentive Plan.

When was the Plan amendment approved?

Stockholders approved the Plan amendment at a special meeting on July 31, 2025.

Does the filing reference prior S-8 registrations?

Yes; it incorporates by reference Form S-8 filings of 866,253 shares (Dec 10, 2021) and 550,000 shares (Apr 25, 2025), adjusted for the 1-for-40 reverse split.

Are there financial results or dilution schedules in this filing?

No. The Form S-8 is an equity registration statement and does not include earnings data or detailed dilution schedules.

What exhibits accompany the registration statement?

Exhibits include the Certificate of Amendment, Plan amendment, amended bylaws, legal opinion, auditor consent, power of attorney, and filing fee table.
Know Labs

NYSE:KNW

KNW Rankings

KNW Latest News

KNW Latest SEC Filings

KNW Stock Data

791.52M
6.23M
3.78%
0.08%
8.59%
Scientific & Technical Instruments
Measuring & Controlling Devices, Nec
Link
United States
SEATTLE